Sumitomo Chemical Co. has announced a major reorganization to consolidate its biorationals business, merging three subsidiaries — Valent BioSciences LLC (VBS), McLaughlin Gormley King Co (MGK), and Valent North America LLC (VNA) — into a newly named entity, Sumitomo Biorational Co LLC (SBC).

The new entity is set to begin operations in April 2026 and will act as the global hub for the company’s biorational innovation, integrating research, manufacturing, and sales under a single structure to enhance operational efficiency.

Sumitomo’s Agro and Life Solutions sector will continue to focus on crop protection chemicals and biorationals as its two core pillars. The biorationals market is expected to grow significantly, with Sumitomo targeting sales of ¥150 billion ($981 million) by 2030, more than double its 2024 sales.

SBC will drive innovation and sustainable value creation across multiple sectors, including agriculture, public health, forest health, pest control, and animal health.

Additionally, Valent USA LLC, a VNA subsidiary, will transition into SBC, continuing its role in crop protection product development, sales, and marketing across the US, Canada, and Mexico.

This move reflects Sumitomo Chemical’s strategy to strengthen its global leadership in the biorationals market while promoting sustainable and environmentally harmonious solutions.